METASTATIC NON-SMALL LUNG CELL CANCER

Clinical trials for METASTATIC NON-SMALL LUNG CELL CANCER explained in plain language.

Never miss a new study

Get alerted when new METASTATIC NON-SMALL LUNG CELL CANCER trials appear

Sign up with your email to follow new studies for METASTATIC NON-SMALL LUNG CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug targets multiple KRAS mutations in advanced cancers

Disease control Recruiting now

This early-stage trial is testing a new drug called BBO-11818 in people with advanced cancers that have specific KRAS gene mutations. The study aims to find a safe dose and see if the drug can shrink tumors in cancers like lung, pancreatic, and colorectal cancer. Participants wil…

Matched conditions: METASTATIC NON-SMALL LUNG CELL CANCER

Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

METASTATIC NON-SMALL LUNG CELL CANCER

Get alerted when new METASTATIC NON-SMALL LUNG CELL CANCER trials appear

New drug targets multiple KRAS mutations in advanced cancers